Skip to main content


NextGen Precision Health Neuroscience Seminar – Feb. 13, 2023


For questions about this event, please reach out to Veronica Lemme at

"Biomarkers of Arousal and Regulation in Autism

Presented by: Dr. Stephen Sheinkopf, PhD, Professor and Thompson Endowed Chair in Child Health, University of Missouri

Executive Director, Thompson Center for Autism & Neurodevelopmental Disorders, University of Missouri

Date: Feb. 13, 2023, 4-5 p.m.

Location: Tom and Linda Atkins Family Seminar Room, Roy Blunt NextGen Precision Health Building

Virtual option available

Register here



Autism is associated with unconventional responses to stress and challenge. This talk will describe psychophysiological and observational approaches to studying arousal and regulation in autism. The presentation will utilize a developmental approach, reviewing data from infancy to childhood. It will also contrast two uses of these types of measures in autism research: first to distinguish autism from non-autistic populations and second to stratify individuals within category of autism. These approaches have distinct implications for translating research to future potential clinical applications. 


Speaker BioStephen Sheinkopf

Stephen Sheinkopf is a Professor of Child Health at the University of Missouri and serves as the Executive Director of the Thompson Center for Autism and Neurodevelopmental Disorders. He completed his doctoral training at the University of Miami and his postdoctoral training at Brown Medical School under an NRSA fellowship. Dr. Sheinkopf stayed on at Brown University after fellowship, rising to the rank of Associate Professor of Psychiatry and Pediatrics and taking on leadership roles, including directing the Rhode Island Consortium for Autism Research and Treatment and co-directing the Autism Initiative of the Hassenfeld Child Health Innovation Institute. Dr. Sheinkopf moved to the University of Missouri in 2021, joining Mizzou as the Executive Director of the Thompson Center. Dr. Sheinkopf’s research employs state-of-the-art and novel approaches to studying risk for autism in infancy and on improved understanding of heterogeneous outcomes in autism spectrum disorders.